![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Innovare Labs Private Limited Visakhapatnam In, based in India, is a pharmaceutical company.
One of their significant offerings is Moxifloxacin hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-334 - Rev 00
This Chemical Type CEP, issued on December 07, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2254 associated with this CEP further emphasizes